Parag Jitendra Parikh MD

Radiation Oncology•Detroit, MI

Director, MR-guided Radiation Therapy & Director of GI Radiation Oncology, Henry Ford Cancer Institute

Join to View Full Profile

2800 W. Grand Blvd.Detroit, MI 48202
Phone+1 313-652-2400

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2002 - 2006
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
Washington University in St. Louis School of MedicineClass of 2001

Certifications & Licensure

MI State Medical License 2018 - 2025
IL State Medical License 2012 - 2020
MO State Medical License 2006 - 2019
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
Terminated
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer Start of enrollment: 2009 Nov 01
Completed
Phase 2
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma Start of enrollment: 2009 Dec 16
Completed
Phase 1
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization Start of enrollment: 2012 Oct 25
Terminated
Phase 1
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer Start of enrollment: 2014 Aug 19
Terminated
Phase 1
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Local Ablative Strategies After Endovascular Radioembolization Start of enrollment: 2016 Jan 19
Terminated
Phase 1
Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Start of enrollment: 2016 May 27
Completed
Phase 2
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies Start of enrollment: 2017 Jan 19
Terminated
Phase 2
Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer Start of enrollment: 2019 Jan 01
Active, not recruiting
Not Applicable
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer Start of enrollment: 2021 May 07
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.
Mette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, Susanne Nørring Bekke, Uffe Bernchou
Radiotherapy and Oncology. 2024-03-01
32 citations
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2...
Michael D Chuong, Percy Lee, Daniel A Low, Joshua Kim, Kathryn E Mittauer
Radiotherapy and Oncology. 2024-02-01
6 citations
The Use of MR-Guided Radiation Therapy for Pancreatic Cancer.
Lois A Daamen, Parag J Parikh, William A Hall
Seminars in Radiation Oncology. 2024-01-01

Press Mentions

Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic CancerNovember 21st, 2022
Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session UpdatesOctober 6th, 2022
Henry Ford Health 1st in World to Offer Newest MR-Guided Radiation TherapyJune 3rd, 2022
Join now to see all

Parag Jitendra Parikh MD

Dr. Parikh is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.